| Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis W Liu, P Zhou, K Chen, Z Ye, F Liu, X Li, N He, Z Wu, Q Zhang, X Gong, ... Cmaj 192 (27), E734-E744, 2020 | 97 | 2020 |
| Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database Y Zhao, S Sun, X Li, X Ma, H Tang, L Sun, S Zhai, T Wang International Journal of Clinical Pharmacy 40, 1349-1358, 2018 | 36 | 2018 |
| Efficacy and safety of saxagliptin in patients with type 2 diabetes: a systematic review and meta-analysis P Men, X Li, H Tang, S Zhai PLoS One 13 (5), e0197321, 2018 | 32 | 2018 |
| Use of epinephrine in patients with drug-induced anaphylaxis: an analysis of the Beijing Pharmacovigilance Database T Wang, X Ma, Y Xing, S Sun, H Zhang, T Stürmer, B Wang, X Li, H Tang, ... International archives of allergy and immunology 173 (1), 51-60, 2017 | 21 | 2017 |
| Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database X Li, S Thai, W Lu, S Sun, H Tang, S Zhai, T Wang International journal of clinical pharmacy 40, 921-927, 2018 | 18 | 2018 |
| 《 严重过敏反应急救指南》 推荐意见 李晓桐， 翟所迪， 王强， 王育琴， 尹佳， 陈玉国， 陈荣昌， 张洪君， 杨克虎， ... 药物不良反应杂志 21 (2), 85-91, 2019 | 17 | 2019 |
| A clinical practice guideline for the emergency management of anaphylaxis (2020) X Li, Q Ma, J Yin, Y Zheng, R Chen, Y Chen, T Li, Y Wang, K Yang, ... Frontiers in Pharmacology 13, 845689, 2022 | 12 | 2022 |
| Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database Y Zhao, H Lu, S Thai, X Li, J Hui, H Tang, S Zhai, L Sun, T Wang International journal of clinical pharmacy 40, 862-869, 2018 | 9 | 2018 |
| Chat GPT-4 significantly surpasses GPT-3.5 in drug information queries N He, Y Yan, Z Wu, Y Cheng, F Liu, X Li, S Zhai Journal of Telemedicine and Telecare, 1357633X231181922, 2023 | 8 | 2023 |
| Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the US Food and Drug Administration Adverse Event Reporting System X Li, L Zhou, M Gaggl, AC Kinlaw, Z Gou, Y Xu, J Wei, T Wang International Journal of Clinical Pharmacy 45 (2), 509-514, 2023 | 6 | 2023 |
| Correspondence on ‘Warfarin use and risk of knee and hip replacements’ N He, Z Fang, X Li, S Zhai Annals of the rheumatic diseases 82 (7), e172-e172, 2023 | 5 | 2023 |
| An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through … X Li, P Ndungu, SB Taneja, MR Chapin, SB Egbert, K Akenapalli, ... Clinical and Translational Science 16 (6), 1002-1011, 2023 | 5 | 2023 |
| 奥洛他定片剂治疗过敏性鼻炎和荨麻疹的卫生技术评估 李晓桐， 郑航慈， 门鹏， 马翔， 翟所迪 中国新药杂志 27 (12), 1443-1448, 2018 | 2 | 2018 |
| 《 严重过敏反应急救指南》 临床问题与结局指标的收集和确定 郑航慈， 李晓桐， 门鹏， 马翔， 王强， 陈耀龙， 翟所迪 Journal of Peking University (Health Sciences) 52 (4), 715, 2020 | | 2020 |
| Selecting and defining the clinical questions and outcomes of Guideline for the Emergency Treatment of Anaphylaxis HC Zheng, XT Li, P Men, X Ma, Q Wang, YL Chen, SD Zhai Beijing da xue xue bao. Yi xue ban= Journal of Peking University. Health …, 2020 | | 2020 |
| 基于 AGREEⅡ 的严重过敏反应诊疗指南质量评价 李晓桐， 崔畅， 郑航慈， 翟所迪 药物流行病学杂志, 2020 | | 2020 |
| Glucocorticosteroids for the treatment of anaphylaxis: A systematic review X Li, Y Xiong, S Zhai PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 547-547, 2019 | | 2019 |
